CNTX - Company ID 0001842952
The table below shows Context Therapeutics Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $66.00M | $94.43M | $14.45M | $35.50M | $49.64M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $68.35M | $97.90M | $16.05M | $37.85M | $51.26M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $29.66K | $11.96K | $15.52K | $27.57K | - |
| Goodwill | - | - | - | - | - |
| Total assets | $68.49M | $98.13M | $16.06M | $37.97M | $51.31M |
| Accounts payable | $2.53M | $1.45M | $2.38M | $936.33K | $1.83M |
| Total current liabilities | $8.02M | $2.75M | $4.19M | $3.21M | $3.03M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $8.02M | $2.86M | $4.19M | $3.21M | $3.03M |
| Retained earnings | -$130.90M | -$94.78M | -$68.05M | -$44.09M | -$29.25M |
| Total equity | $60.47M | $95.27M | $11.87M | $34.76M | $48.27M |